Not applicableStudy completedNCT03000816What this trial is testingSBRT for OligoMetastatic ESCCWho this might be right forEsophageal Squamous Cell Carcinoma Metastatic Fudan University 34
Early research (Phase 1)Active Not RecruitingNCT04603287What this trial is testingSI-B001, an EGFR/HER3 Bispecific Antibody, in Locally Advanced or Metastatic Epithelial TumorsWho this might be right forLocally Advanced or Metastatic Epithelial Tumor Sichuan Baili Pharmaceutical Co., Ltd. 60
Early research (Phase 1)Looking for participantsNCT06465069What this trial is testingLY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsWho this might be right forMetastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more Eli Lilly and Company 420
Testing effectiveness (Phase 2)Study completedNCT00268346What this trial is testingGefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction CancerWho this might be right forEsophageal Cancer Case Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT01469598What this trial is testingStudy of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell CancerWho this might be right forMetastatic CarcinomaRecurrent Esophageal Squamous Cell Carcinoma Samsung Medical Center 24
Early research (Phase 1)Looking for participantsNCT07090499What this trial is testingLearn About the Study Medicine Called PF-08046876 in People With Advanced Solid TumorsWho this might be right forAdvanced/Metastatic Solid TumorsBladder CancerUrothelial Carcinoma+10 more Pfizer 540
Early research (Phase 1)Study completedNCT03708328What this trial is testingA Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid TumorsWho this might be right forSolid TumorsMetastatic MelanomaNon-small Cell Lung Cancer (NSCLC)+2 more Hoffmann-La Roche 134
Not applicableActive Not RecruitingNCT06504615What this trial is testingObservational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in FranceWho this might be right forGastric AdenocarcinomaGastro-esophageal Junction AdenocarcinomaEsophageal Adenocarcinoma (EAC)+1 more Bristol-Myers Squibb 208
Testing effectiveness (Phase 2)Looking for participantsNCT07811752What this trial is testingSacituzumab Govitecan Combined With Tislelizumab for Locally Advanced/Metastatic Esophageal CancerWho this might be right forEsophageal Squamous Cell Carcinoma Shanghai Chest Hospital 28
Testing effectiveness (Phase 2)UnknownNCT05221658What this trial is testingA Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy or Monotherapy in Patients With Advanced ESCCWho this might be right forESCC or Esophageal Adenosquamous Carcinoma Shanghai Henlius Biotech 60
Testing effectiveness (Phase 2)Looking for participantsNCT07730021What this trial is testingASP388B Given by Itself and With Standard Therapies in Participants With Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid Tumors Astellas Pharma Global Development, Inc. 392
Early research (Phase 1)Study completedNCT00019110What this trial is testingVaccine Therapy in Treating Patients With Advanced or Recurrent CancerWho this might be right forAnal CancerCervical CancerEsophageal Cancer+3 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT05866510What this trial is testingUtidelone and Anlotinib in Advanced Recurrent Metastatic Esophageal CancerWho this might be right forEsophageal Cancer Peking University 47
Testing effectiveness (Phase 2)UnknownNCT02353936What this trial is testingA Phase II Trial of Afatinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of EsophagusWho this might be right forSquamous Cell Carcinoma of Esophagus Yonsei University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06746961What this trial is testingEfficacy and Safety of QL1706 Plus Lenvatinib As 2nd Line Theapy in Patients with Metastatic Esophageal Carcinoma After Disease Progression on ICIs TherapyWho this might be right forEsophageal Squamous Cell Carcinoma (ESCC) The First Affiliated Hospital of Zhengzhou University 49
Testing effectiveness (Phase 2)UnknownNCT03185988What this trial is testingAnti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive SystemWho this might be right forTargeted TherapyHER2Biliary Tract Cancer+2 more Shen Lin 100
Testing effectiveness (Phase 2)UnknownNCT03785496What this trial is testingStudy to Evaluate Efficacy of PDR001 in Patients With Squamous Cell Carcinoma of the EsophagusWho this might be right forHistologically Confirmed Unresectable or Metastatic Squamous Cell Carcinoma of the Esophagus Who Failed on Standard Treatment Yonsei University 44
Testing effectiveness (Phase 2)Looking for participantsNCT06769113What this trial is testingA Phase II Clinical Study to Evaluate HLX43 in Patients With Recurrent/Metastatic ESCC Failed or Intolerance to Standard TherapyWho this might be right forEsophageal Cancer Shanghai Henlius Biotech 102
Testing effectiveness (Phase 2)UnknownNCT03770988What this trial is testingA Trial to Evaluate the Efficacy of Poziotinib, Pan HER Inhibitor in Recurrent/Metastatic Esophageal Cancer (R/M ESCC)Who this might be right forInoperable or Recurrent or Metastatic Esophageal Squamous Carcinoma Yonsei University 49
Large-scale testing (Phase 3)Study completedNCT03933449What this trial is testingStudy of Pembrolizumab (MK-3475) Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)-China Extension StudyWho this might be right forEsophageal CarcinomaEsophagogastric Junction Carcinoma Merck Sharp & Dohme LLC 123